StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3025% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Jardiance by Quarter

Jardiance — Worldwide revenue growth YoY (%) [Q1–Q3 10-Q & FY through FY2024] (%)

QuarterlyAnnual

Eli Lilly Jardiance: 79.0% in Q2 2026, down 261.7 pts from a year earlier.

Latest, Q2 2026
79.0%
Period ended Jun 30, 2026
Change on a year earlier
-261.7 pts
340.7% in Q2 2025
History
31 quarters
Since Q1 2018
Sources
31
Documents cited below

Where the Q2 2026 figure comes from

“|| Jardiance (2) | 616 | 615 | 1,232 | 690 | 79”

Source: Form 10-Q FY2026Q2 (filed 2026-08-05) ↗

Reported in Form 10-Q MD&A & Form 10-K through FY2024.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedJardiance — Worldwide revenue growth YoY (%) [Q1–Q3 10-Q & FY through FY2024] (%)Year on yearSource
Q2 2026Jun 30, 202679.0%-261.7 ptsForm 10-Q FY2026Q2 (filed 2026-08-05) ↗
Q1 2026Mar 31, 202610.0%-308.3 ptsForm 10-Q FY2026Q1 (filed 2026-04-30) ↗
Q3 2025Sep 30, 2025350.5%+352.5 ptsForm 10-Q FY2025Q3 (filed 2025-10-30) ↗
Q2 2025Jun 30, 2025340.7%+325.7 ptsForm 10-Q FY2025Q2 (filed 2025-08-07) ↗
Q1 2025Mar 31, 2025318.3%+299.3 ptsForm 10-Q FY2025Q1 (filed 2025-05-01) ↗
Q4 2024Dec 31, 202450.0%+20.0 ptsEarnings Release (Form 8-K FY2024Q4 EX-99.1) (filed 2025-02-06) ↗
Q3 2024Sep 30, 2024-2.0%-24.0 ptsForm 10-Q FY2024Q3 (filed 2024-10-30) ↗
Q2 2024Jun 30, 202415.0%-30.0 ptsForm 10-Q FY2024Q2 (filed 2024-08-08) ↗
Q1 2024Mar 31, 202419.0%-19.0 ptsForm 10-Q FY2024Q1 (filed 2024-04-30) ↗
Q4 2023Dec 31, 202330.0%-12.0 ptsEarnings Release (Form 8-K FY2023Q4 EX-99.1) (filed 2024-02-06) ↗
Q3 2023Sep 30, 202322.0%-25.0 ptsForm 10-Q FY2023Q3 (filed 2023-11-02) ↗
Q2 2023Jun 30, 202345.0%+16.0 ptsForm 10-Q FY2023Q2 (filed 2023-08-08) ↗
Q1 2023Mar 31, 202338.0%+4.0 ptsForm 10-Q FY2023Q1 (filed 2023-04-27) ↗
Q4 2022Dec 31, 202242.0%+4.0 ptsEarnings Release (Form 8-K FY2022Q4 EX-99.1) (filed 2023-02-02) ↗
Q3 2022Sep 30, 202247.0%+21.0 ptsForm 10-Q FY2022Q3 (filed 2022-11-01) ↗
Q2 2022Jun 30, 202229.0%-7.0 ptsForm 10-Q FY2022Q2 (filed 2022-08-04) ↗

Cite this data

StockData. (2026). Eli Lilly Jardiance (%), quarterly Q1 2018–Q2 2026 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/med-jardiance-yoy

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.